Senior insider sale
Chief Operating Officer at PALVELLA THERAPEUTICS, INC. — senior position signals high conviction
$1.55M
17.21K shares
What this filing means
GOIN KATHLEEN plans to sell 17.21K shares of PALVELLA THERAPEUTICS, INC. valued at approximately $1.55M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/18/2026ACC: 0001967940-26-000004
Officer· Chief Operating Officer
Since Feb 2026
17.21K
Shares to sell
$1.55M
Approx. market value
4.30K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Option Exercise
Cash
2/18/2026
4.30KTotal acquired4.30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/18/2026 | Option Exercise Cash | 4.30K | — |
| Total | 4.30K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
4.30K
Market value
$420.0K
1/21/2026
—Completed
Units to sell
4.30K
Market value
$415.0K
12/17/2025
—Completed
Units to sell
4.30K
Market value
$371.0K
11/19/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
4.30K
Market value
$344.5K
2/18/2026
Total
Units
17.21K
Value
$1.55M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/21/2026 | 4.30K | $420.0K | — | Completed |
12/17/2025 | 4.30K | $415.0K | — | Completed |
11/19/2025 | 4.30K | $371.0K | — | Completed |
| Planned — Approximate Date | ||||
2/18/2026 | 4.30K | $344.5K | Nasdaq | Planned |
| Total | 17.21K | $1.55M | ||